• On 21 March 2026, The Clorox Company was removed from the FTSE All-World Index (USD) after a period of weaker-than-expected earnings tied to muted demand, ERP-related disruptions, and higher costs.
• This index exit highlights how operational setbacks and competitive pressures can influence a company's standing in global benchmarks and institutional portfolios.
• We’ll now examine how Clorox’s index removal, amid ongoing ERP and demand challenges, could reshape the company’s broader investment narrative.

Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.

Clorox Investment Narrative Recap

To own Clorox, you need to believe its core brands can work through muted demand, ERP disruption, and higher costs without permanently eroding earnings power. The FTSE All-World removal itself is largely a symptom of those pressures rather than a new driver, but it does sharpen focus on whether ERP stabilization is the key near term catalyst or whether softer volumes and consumer trading down remain the bigger risk.

The most relevant recent development here is Clorox’s February 2026 earnings release, which showed Q2 sales of US$1,673 million and net income of US$157 million, both below the prior year. Against the backdrop of index removal, these results frame the debate around whether ERP and supply chain investments can still deliver the expected productivity benefits or whether weaker demand and competition will keep earnings and margins under pressure.

Yet beneath the ERP story, investors should also be aware that rising price competition in core categories could...

Clorox's narrative projects $7.0 billion revenue and $881.8 million earnings by 2028.

Uncover how Clorox's forecasts yield a $119.76 fair value, a 16% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts were already cautious, assuming revenues fall to about US$6.8 billion and earnings dip to roughly US$801 million, so this index exit could reinforce their view that Clorox’s demand and innovation challenges may be tougher to fix than the consensus expects.

Explore 7 other fair value estimates on Clorox - why the stock might be worth over 2x more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Clorox research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Clorox research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Clorox's overall financial health at a glance.

Interested In Other Possibilities?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Outshine the giants: these 20 early-stage AI stocks could fund your retirement.
• Find 58 companies with promising cash flow potential yet trading below their fair value.
• Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.